| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 21, 2013 | New Constructs, LLC | N/A | GERN: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 21, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | GERON CORPORATION DELAWARE (GERN) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | GERON CORPORATION DELAWARE (GERN) 12-months forecast | 1 | $15 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: GERON -- GERN | 1 | $11.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS | 3 | $34.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for GERN | 11 | $126.50 | | May 11, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: GERON CORP | 5 | $10 | | May 10, 2013 | S&P Capital IQ Quantitative Report | N/A | Geron Corp | 6 | $69 | | May 4, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: GERON CORP | 5 | $10 |
|
View All Reports for GERN ... |
|
|
0.02(1.79%) May 22, 4:00PM EDT|After Hours
:
1.10 0.00 (0.00%) May 22, 4:31PM EDT